01 Dr. Reddy's Laboratories (8)
02 Breckenridge Pharmaceutical (4)
03 Apotex Inc (4)
04 Aurobindo Pharma Limited (4)
05 Bristol Laboratories Ltd (4)
06 Celgene Corporation (28)
07 DR REDDY'S LABORATORIES LTD (4)
08 JAMP PHARMA (4)
09 Juno Pharmaceuticals Pty Ltd (16)
10 Key Oncologics (4)
11 Laboratorio Eczane Pharma (4)
12 Natco Pharma (Canada) Inc (4)
13 Sakar Healthcare (1)
14 Sandoz B2B (12)
15 Tecnimede (4)
16 Teva Pharmaceutical Industries (4)
17 Viatris (4)
18 XYZ Pharma (4)
01 CAP (4)
02 CAPSULE (24)
03 CAPSULE;ORAL (24)
04 Capsule (16)
05 Capsule, hard (4)
06 Capsules (1)
07 HARD CAPSULES (4)
08 Oral Solid Dosage Form (4)
09 Pomalidomide 1Mg 21 Combined Oral Use (1)
10 Pomalidomide 2Mg 21 Combined Oral Use (1)
11 Pomalidomide 3Mg 21 Combined Oral Use (1)
12 Pomalidomide 4Mg 21 Combined Oral Use (1)
13 capsule (12)
14 Blank (20)
01 DISCN (16)
02 Lead Market Dossiers- Filed (4)
03 Lead Market Dossiers- TentativenApproved in US (4)
04 Originator (4)
05 Prescription (24)
06 RX (4)
07 Blank (61)
01 APO-POMALIDOMIDE (4)
02 Imnovid (12)
03 Imnovid 1 mg (1)
04 Imnovid 2 mg (1)
05 Imnovid 3 mg (1)
06 Imnovid 4 mg (1)
07 JAMP POMALIDOMIDE (4)
08 NAT-POMALIDOMIDE (4)
09 POMALIDOMIDE (20)
10 POMALYST (8)
11 Pomalidomida Eczane (4)
12 Pomalidomide Sandoz (8)
13 Pomalyst (8)
14 Pomolide (16)
15 REDDY-POMALIDOMIDE (4)
16 SANDOZ POMALIDOMIDE (4)
17 Blank (17)
01 Argentina (4)
02 Australia (32)
03 Canada (24)
04 India (9)
05 Italy (4)
06 Norway (4)
07 Portugal (4)
08 South Africa (4)
09 Sweden (4)
10 Switzerland (4)
11 USA (24)